Issue Date: June 12, 2017 | Web Date: June 6, 2017
Contract manufacturer AMRI to go private
In the latest deal to hit the pharmaceutical contract manufacturing industry, Albany Molecular Research Inc. has agreed to be acquired by two private equity firms for more than $1.5 billion, including debt.
The two investment firms, Carlyle Group and GTCR, are paying $21.75 per share, which is a 42% premium to AMRI’s average share price prior to April 5, when rumors of a possible sale emerged.
The deal is the third large transaction in recent . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society